Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening

Submitted by Frida Mäkelä on Thu, 05/23/2024 - 09:37
  • Read more about Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening

Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 05/23/2024 - 09:34
  • Read more about Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study

Deep learning of left atrial structure and function provides link to atrial fibrillation risk

Submitted by Frida Mäkelä on Thu, 05/23/2024 - 09:31
  • Read more about Deep learning of left atrial structure and function provides link to atrial fibrillation risk

Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study

Submitted by Frida Mäkelä on Thu, 05/23/2024 - 09:29
  • Read more about Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study

Potential drug targets for tumors identified through Mendelian randomization analysis

Submitted by Frida Mäkelä on Thu, 05/23/2024 - 09:20
  • Read more about Potential drug targets for tumors identified through Mendelian randomization analysis

Association between allergic diseases and both psoriasis and psoriatic arthritis: a bidirectional 2-sample Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 05/23/2024 - 09:18
  • Read more about Association between allergic diseases and both psoriasis and psoriatic arthritis: a bidirectional 2-sample Mendelian randomization study

Causal association of sleep traits with the risk of thyroid cancer: A mendelian randomization study

Submitted by Frida Mäkelä on Thu, 05/23/2024 - 09:15
  • Read more about Causal association of sleep traits with the risk of thyroid cancer: A mendelian randomization study

Genetic Association between Lipid-Regulating Drug Targets and Diabetic Retinopathy: A Drug Target Mendelian Randomization Study

Submitted by Frida Mäkelä on Fri, 05/17/2024 - 15:19
  • Read more about Genetic Association between Lipid-Regulating Drug Targets and Diabetic Retinopathy: A Drug Target Mendelian Randomization Study

Genome-Wide Association Study Identifies Novel Genetic Variants Associated with Widespread Pain in the UK Biobank (N=172,230)

Submitted by Frida Mäkelä on Fri, 05/17/2024 - 09:44
  • Read more about Genome-Wide Association Study Identifies Novel Genetic Variants Associated with Widespread Pain in the UK Biobank (N=172,230)

Causal relationships between blood metabolites and diabetic retinopathy: a two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 05/16/2024 - 17:33
  • Read more about Causal relationships between blood metabolites and diabetic retinopathy: a two-sample Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 297
  • Page 298
  • Page 299
  • Page 300
  • Current page 301
  • Page 302
  • Page 303
  • Page 304
  • Page 305
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement